Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probability models and computational models for ANOVA in multicenter clinical trials.

Thomas Permutt1

  • 1Food and Drug Administration, Rockville, Maryland 20857, USA. permuttT@cder.fda.gov

Journal of Biopharmaceutical Statistics
|August 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.

Pharmaceutical statistics·2025
Same author

Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis.

Pharmaceutical statistics·2020
Same author

Defining treatment effects: A regulatory perspective.

Clinical trials (London, England)·2019
Same author

Defining Treatment Effects: A Primer for Nonstatisticians.

Clinical pharmacology and therapeutics·2018
Same author

Considerations for Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.

Clinical pharmacology and therapeutics·2018
Same author

Author's reply to comments on "A taxonomy of estimands for regulatory clinical trials with discontinuations".

Statistics in medicine·2017

Analyzing multicenter trials using mixed-effects models with random treatment-by-center interaction can improve results. This approach offers a more appropriate statistical analysis for complex trial data.

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Statistical Modeling

Background:

  • Multicenter trials are commonly analyzed using fixed-effects, two-way analysis of variance.
  • This standard approach may not fully capture the complexities of treatment effects across different centers.

Purpose of the Study:

  • To evaluate the benefits of using mixed-effects models for analyzing multicenter trials.
  • To explore the impact of considering treatment-by-center interaction as a random effect.

Main Methods:

  • Comparison of fixed-effects, two-way analysis of variance with mixed-effects models.
  • Implementation of random treatment-by-center interaction in statistical computations.

Main Results:

Related Experiment Videos

  • Mixed-effects computation with random treatment-by-center interaction can yield superior results compared to traditional methods.
  • Treating the interaction as a random effect is often more statistically appropriate.

    • Conclusions:

    • Mixed-effects models offer a more robust framework for analyzing multicenter trials.
    • Randomizing the treatment-by-center interaction provides a more accurate representation of trial data.